Compare Axogen Inc (AXGN) vs Oracle Corporation (ORCL) Price & Performance

Axogen IncTrade

Oracle CorporationTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs Oracle Corporation — how do they compare? Axogen Inc trades at $49.66 (market cap $2.61B), while Oracle Corporation trades at $153.19 (market cap $419.05B). The key difference: Oracle Corporation is far larger — about 160.6× Axogen Inc's market cap, and Oracle Corporation pays a 1.37% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

	AXGN	ORCL
Market Cap	$2.61B	$419.05B
Sector	Technology	Technology
52-Week High	$48.48	$328.33
52-Week Low	$14.16	$114.99
Enterprise Value	$2.52B	$548.30B
Dividend Yield	—	1.37%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $49.67, up 3.01% with strong technical momentum. The stock shows bullish moving average signals despite recent earnings misses. Q2 2026 revenue grew 23.1% to $69.7M with raised full-year guidance to $279M, though net margins remain negative at -13.36%. Analyst consensus is strongly bullish with 16 buy ratings and $54.33 price target.

Growth prospects appear strong with expanding nerve care platform and reimbursement wins, but profitability challenges and high valuation multiples present risks. The stock trades near resistance at $50 with RSI indicating overbought conditions, suggesting potential near-term consolidation before further upside.

Oracle Corporation

Oracle Corporation (ORCL) trades at $151.04, up 2.79% with strong technical momentum. The stock shows robust fundamentals with 21.67% net profit margin and consistent earnings beats in recent quarters. Oracle's AI infrastructure positioning and partnership with OpenAI have driven investor optimism, though RSI levels suggest potential overbought conditions. The company maintains solid cash flow generation with $20.82B from operations in 2025.

Oracle presents a compelling growth story with AI-driven revenue acceleration and strong analyst support (65% buy ratings). Key risks include high valuation multiples and significant debt load. The consensus price target of $252.44 implies substantial upside, but investors should monitor execution on AI investments and competitive pressures in cloud infrastructure.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AXGN

View details →

ORCL

Tech stocks surge as Dell's AI server business grows 757%, boosting market gains.Gordon Thompson · 20 minutes agoBullish Oracle and Supermicro report strong AI-driven growth but face cash flow challenges.24/7 Wall Street · 10 hours agoNeutral Quantinuum reports 279% revenue growth and forms key alliances, boosting quantum computing market position.Alex Lavoie · 11 hours agoBullish View details →

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.